Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine 2021-12-20 08:24
Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma 2021-12-17 22:27
Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China 2021-12-17 19:00
Transcenta Announces the Appointment of Daniel Weng as CFO 2021-12-17 08:30
Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal 2021-12-17 05:16
Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index 2021-12-16 21:00
Bionomics Limited Announces Pricing of Initial Public Offering in the United States 2021-12-16 19:00
Antengene and XtalPi Announce AI-Driven R&D Collaboration 2021-12-16 16:30
BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021 2021-12-16 16:14
Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study 2021-12-16 16:00
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine 2021-12-16 12:03
Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity 2021-12-16 08:30
Statement by WuXi AppTec Regarding Recent Market Fluctuation 2021-12-16 08:00
AUSTRALIAN LIFE SCIENCE COMPANY, QBIOTICS, LAUNCHES STELFONTA® ITS LEAD VETERINARY PHARMACEUTICAL IN AUSTRALIA, FOLLOWING LAUNCHES IN OTHER KEY GLOBAL MARKETS 2021-12-16 03:58
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes 2021-12-15 21:01
JW Therapeutics Presents Primary Clinical Response on Carteyva(R) (relmacabtagene autoleucel injection) in Adults with Relapsed/Refractory Follicular Lymphoma in China at the 63rd ASH Annual Meeting 2021-12-15 10:37
RemeGen Reiterates Commitment to Its Battle Against Autoimmune Disease on World Strengthened Immunity Day 2021 2021-12-15 09:35
GenScript Receives "COVID Management Initiative of the Year" in Singapore Business Review Management Excellence Award 2021 2021-12-15 09:26
ASH 2021 | Ascentage Pharma Releases Long-Term Clinical Data of Olverembatinib (HQP1351) in Oral Presentation Demonstrating Efficacy and Safety 2021-12-14 22:04
CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services 2021-12-14 20:25
1 165 166 167 168 169 415